Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with both type 2 diabetes and chronic kidney disease. The ...
SCIENTISTS BELIEVE SEMAGLUTIDE CAN PREVENT HEART ATTACK ... Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday.Video above: Studies ...
initiation of chronic kidney replacement therapy (dialysis or kidney transplantation), and death from kidney disease or death from CV disease. Findings showed treatment with semaglutide reduced ...
Key Takeaways New data show that GLP1-RA meds like semaglutide can help slow the progression of chronic kidney diseaseThe ...
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...